DS
VBIV

David Shaw’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

David Shaw’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-731
Closed -$8.58K – 4980
2022
Q4 		$8.58K Sell
731
-900
-55% -$15.9K ﹤0.01% 4624
2022
Q3 		$35K Buy
+1,631
New +$44K ﹤0.01% 4735
2020
Q1 		– Sell
-723
Closed -$30K – 4340
2019
Q4 		$30K Sell
723
-1,442
-67% -$31.6K ﹤0.01% 3911
2019
Q3 		$31K Buy
+2,165
New +$45.3K ﹤0.01% 3745

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

David Shaw's VBIV Position: Q1 2023 in Review

David Shaw sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2023, closing a stake of 731 shares — an estimated $8.58K sold.

David Shaw first reported a position in VBIV in Q3 2019 and held it in 4 quarters. The position peaked at $35K in Q3 2022. 95 funds tracked by Wall St. Rank hold VBIV as of Q1 2023.

  • David Shaw reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2023 after selling out during the quarter.
  • David Shaw sold 731 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2023, an estimated $8.58K.
  • David Shaw first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2019 and held it in 4 quarters.
  • David Shaw's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $35K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.